<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig3" class="fig">
 <label class="label">Figure 3</label>
 <caption class="caption">
  <p class="p">Immunophenotyping and cytokine profile of wound tissue in the control group (C, Black bar) and EPA-group (EPA, grey bar). (
   <bold class="bold">A</bold>–
   <bold class="bold">C</bold>) Percentage of positive neutrophils (CD45
   <sup class="sup">+</sup>Ly6G
   <sup class="sup">+</sup>), M1 macrophages (CD45
   <sup class="sup">+</sup>F4/80
   <sup class="sup">+</sup>CD11c
   <sup class="sup">+</sup>), M2 macrophages (CD45
   <sup class="sup">+</sup>F4/80
   <sup class="sup">+</sup>CD206
   <sup class="sup">+</sup>), T helper lymphocytes (CD45
   <sup class="sup">+</sup>TCRb
   <sup class="sup">+</sup>CD4
   <sup class="sup">+</sup>) and T cytotoxic lymphocytes (CD45
   <sup class="sup">+</sup>TCRb
   <sup class="sup">+</sup>CD8
   <sup class="sup">+</sup>) were quantified by flow cytometry in scar tissue harvested: (
   <bold class="bold">A</bold>) before skin lesion (unwounded); (
   <bold class="bold">B</bold>) 3 days after wounding and; (
   <bold class="bold">C</bold>) 10 days after wounding. (
   <bold class="bold">D</bold>) Concentrations of interleukin 1-β (IL- β), tumor necrosis factor-α (TNF-α), keratinocyte chemoattractant (CXCL1), interleukin-6 (IL-6), interleukin-10 (IL-10), vascular endothelial growth factor (
   <italic class="italic">VEGF</italic>), metalloproteinase-9 (MMP-9) and tissue inhbitor of metalloproteinase-1 (TIMP-1) in wound tissue was analyzed by ELISA in tissue collected 1, 3 and 7 days after wounding (n = 5–12 animals/group). Values are expressed as mean ± SD. *p &lt; 0.05; **p &lt; 0.01, ***p &lt; 0.001 indicates significant differences in relation to control as indicated by 
   <italic class="italic">t</italic> Test and Mann Whitney posttest.
  </p>
 </caption>
 <graphic xlink:href="41598_2019_45508_Fig3_HTML" id="d29e732" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
